| Bioactivity | Povorcitinib phosphate is a potent and selective inhibitor of JAK1. Povorcitinib phosphate has the potential for the research of disease selected from cutaneous lupus erythematosus (CLE) and Lichen planus (LP)[1]. |
| Name | Povorcitinib phosphate |
| CAS | 1637677-33-8 |
| Formula | C23H25F5N7O5P |
| Molar Mass | 605.45 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Paul Smith, et al. Use of jak1 inhibitors for the treatment of cutaneous lupus erythematosus and lichen planus (lp). Patent WO2021076124A1. |
Povorcitinib phosphate
CAS: 1637677-33-8 F: C23H25F5N7O5P W: 605.45
Povorcitinib phosphate is a potent and selective inhibitor of JAK1. Povorcitinib phosphate has the potential for th
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.